Re: Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative
- PMID: 30838400
- PMCID: PMC6695300
- DOI: 10.1093/jnci/djz028
Re: Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative
Comment in
-
Response to Peshkin, Isaacs, and Schwartz.J Natl Cancer Inst. 2019 Aug 1;111(8):874. doi: 10.1093/jnci/djz029. J Natl Cancer Inst. 2019. PMID: 30838406 Free PMC article. No abstract available.
Comment on
-
Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative.J Natl Cancer Inst. 2019 Jan 1;111(1):95-98. doi: 10.1093/jnci/djy147. J Natl Cancer Inst. 2019. PMID: 30239769 Free PMC article.
References
-
- Day MB, Pilarski R, Berry MP, et al. NCCN Clinical Practice Guidelines in Oncology. Genetic/familial high-risk assessment: breast and ovarian. Version 3; 2019. https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf. Accessed January 24, 2019.
-
- Thomas MH, Higgs LK, Modesitt SC, Schroen AT, Ring KL, Dillon PM.. Cases and evidence for panel testing in cancer genetics. Is site-specific testing dead? J Genet Counsel. 2019; doi: 10.1002/jgc4.1044. - PubMed